Levetiracetam Injection, Solution, Concentrate
Product Images NDC 25021-780

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 25021-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lev00 0016 01

FDA Label Image

Lev00 0016 02

This appears to be a table showing the percentage of a certain variable across different treatment groups. However, without more context or information on what the variable represents, it is unclear what the practical implications of this data would be.*

FDA Label Image

Lev00 0016 03

This appears to be a table with percentages and medication names. The percentages may represent effectiveness or dosages. However, without further context or headers, it is difficult to provide a complete and accurate description.*

FDA Label Image

Lev00 0016 04

This appears to be a table comparing the effectiveness of Placebo and Levetiracetam at a daily dose of 3,000mg for an unknown condition. The first two lines list percentages, but without context it is unclear what they represent. The table includes two groups - Placebo with 104 participants and Levetiracetam with 180 participants.*

FDA Label Image

Lev00 0016 05

This could be a graph or chart related to clinical trial or medical study, where the percentages denote some kind of statistical measure or result. However, without any context or labels, it is impossible to ascertain what the percentages are actually representing.*

FDA Label Image

Lev00 0016 06

The text shows the percentages of two treatment groups, Placebo and Levetiracetam, for an unknown study with sample sizes of 51 and 58, respectively. Not available information on the context or purpose of the study.*

FDA Label Image

Lev00 0016 07

This appears to be a table containing percentages of patients for two groups, one being a placebo group with 84 patients and the other receiving Levetiracetam, a medication commonly used to treat seizures. However, the text does not provide enough context to understand the purpose or results of this table.*

FDA Label Image

Lev00 0016 08

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.